181 related articles for article (PubMed ID: 38872210)
1. MicroRNA-98: the multifaceted regulator in human cancer progression and therapy.
Hazari V; Samali SA; Izadpanahi P; Mollaei H; Sadri F; Rezaei Z
Cancer Cell Int; 2024 Jun; 24(1):209. PubMed ID: 38872210
[TBL] [Abstract][Full Text] [Related]
2. The microRNA-202 as a Diagnostic Biomarker and a Potential Tumor Suppressor.
Ahmed EA; Rajendran P; Scherthan H
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682549
[TBL] [Abstract][Full Text] [Related]
3. Molecular functions of microRNAs in colorectal cancer: recent roles in proliferation, angiogenesis, apoptosis, and chemoresistance.
Ellakwa DE; Mushtaq N; Khan S; Jabbar A; Abdelmalek MA; Wadan AS; Ellakwa TE; Raza A
Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; ():. PubMed ID: 38619588
[TBL] [Abstract][Full Text] [Related]
4. Emerging roles of miR-145 in gastrointestinal cancers: A new paradigm.
Roshani M; Molavizadeh D; Sadeghi S; Jafari A; Dashti F; Mirazimi SMA; Ahmadi Asouri S; Rajabi A; Hamblin MR; Anoushirvani AA; Mirzaei H
Biomed Pharmacother; 2023 Oct; 166():115264. PubMed ID: 37619484
[TBL] [Abstract][Full Text] [Related]
5. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
6. Unraveling the Multifaceted Role of the miR-17-92 Cluster in Colorectal Cancer: From Mechanisms to Biomarker Potential.
Al-Nakhle HH
Curr Issues Mol Biol; 2024 Feb; 46(3):1832-1850. PubMed ID: 38534736
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic, prognostic role and molecular mechanism of miR-328 in human cancer.
Wang Z; Xie W; Guan H
Biomed Pharmacother; 2023 Jan; 157():114031. PubMed ID: 36413837
[TBL] [Abstract][Full Text] [Related]
8. miR-424: A novel potential therapeutic target and prognostic factor in malignancies.
Dastmalchi N; Baradaran B; Banan Khojasteh SM; Hosseinpourfeizi M; Safaralizadeh R
Cell Biol Int; 2021 Apr; 45(4):720-730. PubMed ID: 33325141
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-3613-3p functions as a tumor suppressor and represents a novel therapeutic target in breast cancer.
Chen C; Pan Y; Bai L; Chen H; Duan Z; Si Q; Zhu R; Chuang TH; Luo Y
Breast Cancer Res; 2021 Jan; 23(1):12. PubMed ID: 33494814
[TBL] [Abstract][Full Text] [Related]
10. miR-451: A Novel Biomarker and Potential Therapeutic Target for Cancer.
Bai H; Wu S
Onco Targets Ther; 2019; 12():11069-11082. PubMed ID: 31908476
[TBL] [Abstract][Full Text] [Related]
11. Double-edged sword role of miRNA-633 and miRNA-181 in human cancers.
Gupta J; Suliman M; Ali R; Margiana R; Hjazi A; Alsaab HO; Qasim MT; Hussien BM; Ahmed M
Pathol Res Pract; 2023 Aug; 248():154701. PubMed ID: 37542859
[TBL] [Abstract][Full Text] [Related]
12. Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agents.
Hashemi M; Mirdamadi MSA; Talebi Y; Khaniabad N; Banaei G; Daneii P; Gholami S; Ghorbani A; Tavakolpournegari A; Farsani ZM; Zarrabi A; Nabavi N; Zandieh MA; Rashidi M; Taheriazam A; Entezari M; Khan H
Pharmacol Res; 2023 Jan; 187():106568. PubMed ID: 36423787
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-452: a double-edged sword in multiple human cancers.
Karimi Dermani F; Datta I; Gholamzadeh Khoei S
Clin Transl Oncol; 2023 May; 25(5):1189-1206. PubMed ID: 36622551
[TBL] [Abstract][Full Text] [Related]
14. The intricate role of miR-155 in carcinogenesis: potential implications for esophageal cancer research.
Nariman-Saleh-Fam Z; Saadatian Z; Daraei A; Mansoori Y; Bastami M; Tavakkoli-Bazzaz J
Biomark Med; 2019 Feb; 13(2):147-159. PubMed ID: 30672305
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-381-A Key Transcriptional Regulator: Its Biological Function and Clinical Application Prospects in Cancer.
Zeng X; Cao Z; Luo W; Zheng L; Zhang T
Front Oncol; 2020; 10():535665. PubMed ID: 33324542
[TBL] [Abstract][Full Text] [Related]
16. miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer.
Vo DT; Karanam NK; Ding L; Saha D; Yordy JS; Giri U; Heymach JV; Story MD
Neoplasia; 2019 Sep; 21(9):849-862. PubMed ID: 31325708
[TBL] [Abstract][Full Text] [Related]
17. Deciphering the oncogenic landscape: Unveiling the molecular machinery and clinical significance of LncRNA TMPO-AS1 in human cancers.
Saraswat SK; Mahmood BS; Ajila F; Kareem DS; Alwan M; Athab ZH; Shaier JB; Hosseinifard SR
Pathol Res Pract; 2024 Mar; 255():155190. PubMed ID: 38330619
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of microRNAs that synergize with miR-34a - a basis for combinatorial microRNA therapeutics.
Orellana EA; Li C; Lisevick A; Kasinski AL
Cell Cycle; 2019 Aug; 18(15):1798-1811. PubMed ID: 31258013
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-34b functions as a tumor suppressor and acts as a nodal point in the feedback loop with Met.
Wang LG; Ni Y; Su BH; Mu XR; Shen HC; Du JJ
Int J Oncol; 2013 Mar; 42(3):957-62. PubMed ID: 23314612
[TBL] [Abstract][Full Text] [Related]
20. Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC).
Lu YF; Yu JR; Yang Z; Zhu GX; Gao P; Wang H; Chen SY; Zhang J; Liu MY; Niu Y; Wei XM; Wang W; Ye FJ; Zhang LX; Zhao Y; Sun GG
J Exp Clin Cancer Res; 2018 Dec; 37(1):301. PubMed ID: 30514328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
